LifeMD, Inc. (LFMD) Tops Q4 EPS by 3c, provides guidance

LifeMD, Inc. (NASDAQ: LFMD) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $46.87 million versus the consensus estimate of $49.07 million.

GUIDANCE:

LifeMD, Inc. sees Q1 2026 revenue of $48-49 million, versus the consensus of $50.57 million.

LifeMD, Inc. sees FY2026 revenue of $220-230 million, versus the consensus of $222.6 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• Occidental Petroleum releases Q2 2026 earnings considerations
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'